Boon WM - Search Results

1

Progress in promoting data sharing in public health emergencies.

Littler K, Boon WM, Carson G, Depoortere E, Mathewson S, Mietchen D, Moorthy VS, O'Connor D, Roth C, Segovia C. Littler K, et al. Among authors: boon wm. Bull World Health Organ. 2017 Apr 1;95(4):243. doi: 10.2471/BLT.17.192096. Bull World Health Organ. 2017. PMID: 28479616 Free PMC article. No abstract available.

2

NHMRC initiatives to improve access to research outputs and findings.

Boon WM, Leves F. Boon WM, et al. Med J Aust. 2015 Jun 15;202(11):558. doi: 10.5694/mja15.00550. Med J Aust. 2015. PMID: 26068673 No abstract available.

3

Safety, tolerability and pharmacokinetic characterisation of DACRA KBP-042 in healthy male subjects.

Henriksen K, Broekhuizen K, de Boon WMI, Karsdal MA, Bihlet AR, Christiansen C, Dillingh MR, de Kam M, Kumar R, Burggraaf J, Kamerling IMC. Henriksen K, et al. Among authors: de boon wmi. Br J Clin Pharmacol. 2021 Dec;87(12):4786-4796. doi: 10.1111/bcp.14921. Epub 2021 Jun 18. Br J Clin Pharmacol. 2021. PMID: 34019711 Free article. Clinical Trial.

4

Quantification of tremor using consumer product accelerometry is feasible in patients with essential tremor and Parkinson's disease: a comparative study.

van Brummelen EMJ, Ziagkos D, de Boon WMI, Hart EP, Doll RJ, Huttunen T, Kolehmainen P, Groeneveld GJ. van Brummelen EMJ, et al. Among authors: de boon wmi. J Clin Mov Disord. 2020 Apr 7;7:4. doi: 10.1186/s40734-020-00086-7. eCollection 2020. J Clin Mov Disord. 2020. PMID: 32280482 Free PMC article.

5

The Pharmacodynamic Effects of a Dopamine-Somatostatin Chimera Agonist on the Cardiovascular System.

van Esdonk MJ, Stevens J, Stuurman FE, de Boon WMI, Dehez M, van der Graaf PH, Burggraaf J. van Esdonk MJ, et al. Among authors: de boon wmi. J Cardiovasc Pharmacol. 2019 Aug;74(2):128-136. doi: 10.1097/FJC.0000000000000695. J Cardiovasc Pharmacol. 2019. PMID: 31306369 Clinical Trial.

6

A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced GH Secretion in a First-in-Human Clinical Trial.

de Boon WMI, van Esdonk MJ, Stuurman FE, Biermasz NR, Pons L, Paty I, Burggraaf J. de Boon WMI, et al. J Clin Endocrinol Metab. 2019 Mar 1;104(3):883-891. doi: 10.1210/jc.2018-01364. J Clin Endocrinol Metab. 2019. PMID: 30371791 Clinical Trial.

7

Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.

Tare M, Kalidindi RS, Bubb KJ, Parkington HC, Boon WM, Li X, Sobey CG, Drummond GR, Ritchie RH, Kemp-Harper BK. Tare M, et al. Among authors: boon wm. Naunyn Schmiedebergs Arch Pharmacol. 2017 Apr;390(4):397-408. doi: 10.1007/s00210-016-1336-1. Epub 2017 Jan 10. Naunyn Schmiedebergs Arch Pharmacol. 2017. PMID: 28074232

8

A multi-agent cell-based model for wound contraction.

Boon WM, Koppenol DC, Vermolen FJ. Boon WM, et al. J Biomech. 2016 May 24;49(8):1388-1401. doi: 10.1016/j.jbiomech.2015.11.058. Epub 2015 Dec 12. J Biomech. 2016. PMID: 26805459

9

Endothelial cell preservation at hypothermic to normothermic conditions using clinical and experimental organ preservation solutions.

Post IC, de Boon WM, Heger M, van Wijk AC, Kroon J, van Buul JD, van Gulik TM. Post IC, et al. Among authors: de boon wm. Exp Cell Res. 2013 Oct 15;319(17):2501-13. doi: 10.1016/j.yexcr.2013.05.011. Epub 2013 Jun 20. Exp Cell Res. 2013. PMID: 23792081

10

Oxygen-dependent delayed fluorescence measured in skin after topical application of 5-aminolevulinic acid.

Harms FA, de Boon WM, Balestra GM, Bodmer SI, Johannes T, Stolker RJ, Mik EG. Harms FA, et al. Among authors: de boon wm. J Biophotonics. 2011 Oct;4(10):731-9. doi: 10.1002/jbio.201100040. Epub 2011 Jul 19. J Biophotonics. 2011. PMID: 21770036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters